EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non‐Invasive, High‐Resolution ( 1 H 2 O) Metabolic Activity Diffusion Imaging [MADI] of Rat Glioma

Joshua W Schlegel, Samantha M Holland, Felice D Kelly, Eric M Baker, Jared Stoller, William Packwood, Xin Li, Ramon F Barajas, Charles S Springer, Martin M Pike

NMR in Biomedicine · 2026

DOI: 10.1002/nbm.70232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, 2026. Verfasst von Joshua W Schlegel und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Oregon Health and Science University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Diffusion Magnetic Resonance Imaging, Water. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have recently developed a metabolic activity imaging approach entitled Metabolic Activity Diffusion Imaging [MADI] which utilizes diffusion weighted MRI to quantify k io , the homeostatic cellular H 2 O efflux rate constant without the use of contrast agents, thus enabling measurement in both normal and tumor brain regions. Importantly, k io quantifies transmembrane water cycling, a significant proportion of which is coupled to Na + /K + ATPase activity and associated cellular energy utilization, hence constituting a key metabolic biomarker. MADI also quantifies the cell volume (V), and cell density (ρ); these enable quantification of the k io V and k io Vρ products, which convert the k io rate constant to rates of water efflux per cell (units: pL/s/cell) and per tissue (units: pL/s/uL [tissue]), respectively. Representing its first application to brain cancer, MADI was comprehensively evaluated at high field (11.75 T) in rats implanted with syngeneic RG2 brain tumors, and in non‐tumor bearing rats. 18 FDG‐PET images were obtained the following day for comparison with a commonly utilized metabolic imaging modality. A subset of rats were subsequently treated with temozolamide and radiation. Tumor 18 FDG‐PET SUV max substantially increased while tumor k io V substantially decreased versus contralateral. Edematous peritumoral regions indicated substantially higher k io V values than contralateral. The k io values tended to be moderately higher than contralateral. Similarly, the k io Vρ tended to increase only moderately in tumor versus contralateral suggesting that the marked glycolytic activation did not substantially increase overall tissue energy production. Furthermore, the ratio of cellular water efflux to glucose uptake (WGI), suggested that tumor glycolysis remained a minor contributor to overall energy production. Mean tumor size, MADI tumor parameters, and 18 FDG‐PET [SUV max ] were not significantly altered with treatment. The MADI ρ was compared with that observed from a 3D confocal histological analysis. Our study supports the potential utility of the novel cytometric and metabolic MADI parameters in cancer detection and assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsDiffusion Magnetic Resonance ImagingWaterAnimalsRatsPositron-Emission TomographyMaleCell Line, TumorFluorodeoxyglucose F18

Stichwörter der Autor:innen

DWIPETbraincancercell densitycell volumemetabolic activitywater

Substanzen

WaterFluorodeoxyglucose F18

Autor:innen und Institutionen

  • School of Medicine, Oregon Health and Science University, Portland, Oregon, USA.
  • Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA.
  • Advanced Light Microscopy Core, Oregon Health and Science University, Portland, Oregon, USA.
  • Advanced Imaging Research Center, Oregon Health and Science University, Portland, Oregon, USA.
  • Department of Diagnostic Radiology, Oregon Health and Science University, Portland, Oregon, USA.
  • Small Animal Research Imaging Core, Oregon Health and Science University, Portland, Oregon, USA.

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Schlegel, J. W., Holland, S. M., Kelly, F. D., Baker, E. M., Stoller, J., Packwood, W., Li, X., Barajas, R. F., Springer, C. S., & Pike, M. M. (2026). Non‐Invasive, High‐Resolution ( 1 H 2 O) Metabolic Activity Diffusion Imaging [MADI] of Rat Glioma. NMR in Biomedicine. https://doi.org/10.1002/nbm.70232

Vancouver

Schlegel JW, Holland SM, Kelly FD, Baker EM, Stoller J, Packwood W, et al. Non‐Invasive, High‐Resolution ( 1 H 2 O) Metabolic Activity Diffusion Imaging [MADI] of Rat Glioma. NMR in Biomedicine. 2026. doi:10.1002/nbm.70232

BibTeX
@article{Schlegel2026,
  author = {Schlegel, Joshua W and Holland, Samantha M and Kelly, Felice D and Baker, Eric M and Stoller, Jared and Packwood, William and Li, Xin and Barajas, Ramon F and Springer, Charles S and Pike, Martin M},
  title = {Non‐Invasive, High‐Resolution ( 1 H 2 O) Metabolic Activity Diffusion Imaging [MADI] of Rat Glioma},
  journal = {NMR in Biomedicine},
  year = {2026},
  doi = {10.1002/nbm.70232}
}
Kostenlos starten →